Dottikon Es Holding AG - Asset Resilience Ratio
Dottikon Es Holding AG (DESN) has an Asset Resilience Ratio of 16.69% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Dottikon Es Holding AG strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Dottikon Es Holding AG's Asset Resilience Ratio has changed over time. See DESN net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Dottikon Es Holding AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DESN company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF146.88 Million | 10.57% |
| Short-term Investments | CHF85.00 Million | 6.12% |
| Total Liquid Assets | CHF231.88 Million | 16.69% |
Asset Resilience Insights
- Good Liquidity Position: Dottikon Es Holding AG maintains a healthy 16.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Dottikon Es Holding AG Industry Peers by Asset Resilience Ratio
Compare Dottikon Es Holding AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
BASF SE
F:BASA |
Chemicals | 0.12% |
|
Jinan Shengquan Group Share Holding Co Ltd
SHG:605589 |
Chemicals | 0.07% |
|
Guizhou Redstar Developing Co Ltd
SHG:600367 |
Chemicals | 0.71% |
|
Shanghai Huayi Group Corp Ltd A
SHG:600623 |
Chemicals | 2.10% |
|
Anhui Hwasu Co.Ltd.
SHG:600935 |
Chemicals | 3.81% |
|
Huafon Microfibre Shanghai Co
SHE:300180 |
Chemicals | 0.07% |
|
Solvac S.A.
BR:SOLV |
Chemicals | 0.00% |
|
Jiangxi Chen Guang New Materials Co Ltd
SHG:605399 |
Chemicals | 3.36% |
Annual Asset Resilience Ratio for Dottikon Es Holding AG (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Dottikon Es Holding AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 14.65% | CHF197.77 Million ≈ $250.03 Million |
CHF1.35 Billion ≈ $1.71 Billion |
-2.18pp |
| 2024-03-31 | 16.83% | CHF200.60 Million ≈ $253.62 Million |
CHF1.19 Billion ≈ $1.51 Billion |
-3.97pp |
| 2023-03-31 | 20.80% | CHF219.24 Million ≈ $277.17 Million |
CHF1.05 Billion ≈ $1.33 Billion |
-3.30pp |
| 2022-03-31 | 24.10% | CHF206.84 Million ≈ $261.50 Million |
CHF858.41 Million ≈ $1.09 Billion |
-8.53pp |
| 2021-03-31 | 32.63% | CHF250.16 Million ≈ $316.27 Million |
CHF766.75 Million ≈ $969.39 Million |
+10.61pp |
| 2020-03-31 | 22.02% | CHF107.84 Million ≈ $136.34 Million |
CHF489.84 Million ≈ $619.29 Million |
+12.55pp |
| 2019-03-31 | 9.47% | CHF43.83 Million ≈ $55.42 Million |
CHF463.09 Million ≈ $585.47 Million |
-4.79pp |
| 2018-03-31 | 14.26% | CHF62.50 Million ≈ $79.01 Million |
CHF438.38 Million ≈ $554.23 Million |
+0.93pp |
| 2017-03-31 | 13.33% | CHF50.72 Million ≈ $64.13 Million |
CHF380.51 Million ≈ $481.07 Million |
+10.39pp |
| 2013-03-31 | 2.94% | CHF10.00 Million ≈ $12.64 Million |
CHF339.99 Million ≈ $429.84 Million |
-2.64pp |
| 2012-03-31 | 5.58% | CHF20.00 Million ≈ $25.29 Million |
CHF358.48 Million ≈ $453.21 Million |
-3.96pp |
| 2011-03-31 | 9.54% | CHF35.00 Million ≈ $44.25 Million |
CHF366.80 Million ≈ $463.73 Million |
-- |
About Dottikon Es Holding AG
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blo… Read more